Vanessa Tran

1.5k total citations
41 papers, 884 citations indexed

About

Vanessa Tran is a scholar working on Infectious Diseases, Epidemiology and Obstetrics and Gynecology. According to data from OpenAlex, Vanessa Tran has authored 41 papers receiving a total of 884 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 10 papers in Epidemiology and 10 papers in Obstetrics and Gynecology. Recurrent topics in Vanessa Tran's work include Pregnancy and preeclampsia studies (8 papers), Tuberculosis Research and Epidemiology (7 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). Vanessa Tran is often cited by papers focused on Pregnancy and preeclampsia studies (8 papers), Tuberculosis Research and Epidemiology (7 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). Vanessa Tran collaborates with scholars based in Canada, United States and China. Vanessa Tran's co-authors include Jun Liu, Andrea S. Leung, Baoli Zhu, David C. Alexander, Kevin C. Kain, Andrea L. Conroy, W. Conrad Liles, Xuping Yu, Michael Hawkes and Chloë R. McDonald and has published in prestigious journals such as Nano Letters, PLoS ONE and Scientific Reports.

In The Last Decade

Vanessa Tran

36 papers receiving 875 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vanessa Tran Canada 18 434 314 284 146 141 41 884
Charlotta Nilsson Sweden 21 268 0.6× 393 1.3× 403 1.4× 76 0.5× 207 1.5× 81 1.2k
Victor H. Ferreira Canada 20 546 1.3× 437 1.4× 367 1.3× 66 0.5× 127 0.9× 59 1.3k
Archana Thomas United States 13 165 0.4× 234 0.7× 227 0.8× 152 1.0× 182 1.3× 27 906
Jingyou Yu United States 20 823 1.9× 209 0.7× 451 1.6× 126 0.9× 276 2.0× 49 1.4k
Kinga K. Smolen United States 13 180 0.4× 214 0.7× 230 0.8× 49 0.3× 116 0.8× 37 705
Scott H. James United States 16 228 0.5× 602 1.9× 91 0.3× 72 0.5× 87 0.6× 39 885
Dawn Nolt United States 17 360 0.8× 419 1.3× 189 0.7× 73 0.5× 84 0.6× 34 795
D. K. F. Meijer Netherlands 9 279 0.6× 264 0.8× 117 0.4× 48 0.3× 258 1.8× 13 956
Amanda J. Martinot United States 16 604 1.4× 400 1.3× 386 1.4× 143 1.0× 438 3.1× 35 1.3k
Esther Oiknine‐Djian Israel 16 331 0.8× 213 0.7× 317 1.1× 214 1.5× 69 0.5× 30 817

Countries citing papers authored by Vanessa Tran

Since Specialization
Citations

This map shows the geographic impact of Vanessa Tran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanessa Tran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanessa Tran more than expected).

Fields of papers citing papers by Vanessa Tran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanessa Tran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanessa Tran. The network helps show where Vanessa Tran may publish in the future.

Co-authorship network of co-authors of Vanessa Tran

This figure shows the co-authorship network connecting the top 25 collaborators of Vanessa Tran. A scholar is included among the top collaborators of Vanessa Tran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanessa Tran. Vanessa Tran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mishra, Hridesh, Michelle Ngai, Valerie M. Crowley, et al.. (2025). Soluble tumour necrosis factor receptor 1 predicts hospitalization in children and young adults with dengue virus infection in the Philippines. Cytokine. 190. 156911–156911. 1 indexed citations
2.
Komorowski, Adam S., Alireza Eshaghi, Austin Zygmunt, et al.. (2025). Detection of non-travel-associated, ceftriaxone non-susceptible Neisseria gonorrhoeae FC428-like harbouring the mosaic penA60 allele in Ontario, Canada. Canada Communicable Disease Report. 51(10/11/12). 420–426.
3.
4.
Cooper, Curtis, Abigail Kroch, Rahim Moineddin, et al.. (2025). COVID-19 vaccine uptake in a retrospective population-based cohort of people living with and without HIV in Ontario, Canada. Vaccine. 61. 127422–127422.
5.
6.
Liu, Juan, et al.. (2023). Evaluating HIV Rapid/Point of Care Testing among Risk Factor Groups in Ontario, 2011 to 2018. BMC Public Health. 23(1). 160–160. 1 indexed citations
7.
O’Brien, Sheila F., Steven J. Drews, Qilong Yi, et al.. (2023). Monitoring syphilis serology in blood donors: Is there utility as a surrogate marker of early transfusion transmissible infection behavioral risk?. Transfusion. 63(6). 1195–1203. 10 indexed citations
8.
Weckman, Andrea M., Robyn E. Elphinstone, John M. Ssenkusu, et al.. (2023). Sequential disruptions to inflammatory and angiogenic pathways and risk of spontaneous preterm birth in Malawian women. iScience. 26(6). 106912–106912.
9.
Bolotin, Shelly, Vanessa Tran, Kevin A. Brown, et al.. (2021). SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody Decline. The Journal of Infectious Diseases. 223(8). 1334–1338. 26 indexed citations
10.
Hao, Zhiqi, Benjamin Moore, Frank Macchi, et al.. (2021). Multi-attribute method performance profile for quality control of monoclonal antibody therapeutics. Journal of Pharmaceutical and Biomedical Analysis. 205. 114330–114330. 27 indexed citations
11.
Guthrie, Jennifer L., Kirby Cronin, Adriana Peci, et al.. (2021). Characteristics of SARS-CoV-2 testing for rapid diagnosis of COVID-19 during the initial stages of a global pandemic. PLoS ONE. 16(7). e0253941–e0253941. 5 indexed citations
12.
Peci, Adriana, Vanessa Tran, Jennifer L. Guthrie, et al.. (2021). Prevalence of Co-Infections with Respiratory Viruses in Individuals Investigated for SARS-CoV-2 in Ontario, Canada. Viruses. 13(1). 130–130. 28 indexed citations
13.
Tran, Vanessa, Andrea M. Weckman, Valerie M. Crowley, et al.. (2021). The Angiopoietin-Tie2 axis contributes to placental vascular disruption and adverse birth outcomes in malaria in pregnancy. EBioMedicine. 73. 103683–103683. 15 indexed citations
14.
Walkty, Andrew, Heather J. Adam, Vanessa Tran, et al.. (2018). Failure of a multiplex polymerase chain reaction assay to detect IMP-27 in a clinical isolate of Morganella morganii. Diagnostic Microbiology and Infectious Disease. 92(3). 194–195. 2 indexed citations
15.
Tran, Vanessa, Andrea M. Weckman, & Kevin C. Kain. (2016). Malaria in Pregnancy: An Unrecognized Risk Factor for Neuropsychiatric Disease in Offspring?. 1(3). 1 indexed citations
16.
Tran, Vanessa, et al.. (2016). Loss of Lipid Virulence Factors Reduces the Efficacy of the BCG Vaccine. Scientific Reports. 6(1). 29076–29076. 25 indexed citations
17.
Conroy, Andrea L., Michael Hawkes, Nimerta Rajwans, et al.. (2015). Host biomarkers are associated with progression to dengue haemorrhagic fever: a nested case-control study. International Journal of Infectious Diseases. 40. 45–53. 37 indexed citations
18.
McDonald, Chloë R., Vanessa Tran, & Kevin C. Kain. (2015). Complement Activation in Placental Malaria. Frontiers in Microbiology. 6. 1460–1460. 16 indexed citations
19.
Liu, Jun, Vanessa Tran, Andrea S. Leung, David C. Alexander, & Baoli Zhu. (2009). BCG Vaccines: Their mechanisms of attenuation and impact on safety and protective efficacy. Human Vaccines. 5(2). 70–78. 115 indexed citations
20.
Leung, Andrea S., Vanessa Tran, Zuowei Wu, et al.. (2008). Novel genome polymorphisms in BCG vaccine strains and impact on efficacy. BMC Genomics. 9(1). 413–413. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charlotta Nilsson Breakdown of academic impact, for papers by Victor H. Ferreira Breakdown of academic impact, for papers by Archana Thomas Breakdown of academic impact, for papers by Jingyou Yu Breakdown of academic impact, for papers by Kinga K. Smolen Breakdown of academic impact, for papers by Scott H. James Breakdown of academic impact, for papers by Dawn Nolt Breakdown of academic impact, for papers by D. K. F. Meijer Breakdown of academic impact, for papers by Amanda J. Martinot Breakdown of academic impact, for papers by Esther Oiknine‐Djian
Rankless by CCL
2026